Oncology Institute, Inc. Quarterly Deferred Tax Assets, Valuation Allowance in USD from Q4 2019 to Q4 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.
Summary
Oncology Institute, Inc. quarterly Deferred Tax Assets, Valuation Allowance history and growth rate from Q4 2019 to Q4 2023.
  • Oncology Institute, Inc. Deferred Tax Assets, Valuation Allowance for the quarter ending December 31, 2023 was $54M, a 54.6% increase year-over-year.
Deferred Tax Assets, Valuation Allowance, Quarterly (USD)
Deferred Tax Assets, Valuation Allowance, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q4 2023 $54M +$19.1M +54.6% Dec 31, 2023 10-K 2024-03-28
Q4 2022 $34.9M +$20.2M +137% Dec 31, 2022 10-K 2024-03-28
Q4 2021 $14.7M +$9.27M +170% Dec 31, 2021 10-K 2023-03-16
Q4 2020 $5.45M +$5.45M Dec 31, 2020 10-K 2022-03-11
Q4 2019 $483* Dec 31, 2019 10-K/A 2021-12-14
* An asterisk sign (*) next to the value indicates that the value is likely invalid.